Litigation Details for Chugai Pharmaceutical Co., Ltd. v. Alexion Pharmaceuticals, Inc. (D. Del. 2018)
✉ Email this page to a colleague
Chugai Pharmaceutical Co., Ltd. v. Alexion Pharmaceuticals, Inc. (D. Del. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-11-15 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:1 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | Plaintiff | Referred To | |
| Parties | ALEXION PHARMACEUTICALS, INC.; CHUGAI PHARMACEUTICAL CO., LTD. | ||
| Patents | 10,377,831; 7,722,890; 8,906,377; 8,906,890; 8,980,319; 9,079,949 | ||
| Attorneys | Brian E. Farnan; Brian M. Kramer; Brian W. Nolan; David C. Doyle; Karen Elizabeth Keller; Lisa M. Ferri; Manuel J. Velez; Nathan Roger Hoeschen; Stephen D. Keane; Ying-Zi Yang | ||
| Firms | Farnan LLP; Shaw Keller LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Chugai Pharmaceutical Co., Ltd. v. Alexion Pharmaceuticals, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Biologic Drugs cited in Chugai Pharmaceutical Co., Ltd. v. Alexion Pharmaceuticals, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Chugai Pharmaceutical Co., Ltd. v. Alexion Pharmaceuticals, Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-11-15 | 1 | antibody in U.S. Patent No. 9,079,949 (“the ’949 patent”). 30. The ’949 patent is entitled “Anti-C5…pending patent applications and by U.S. Patent No. 9,890,377 (“the ’377 patent” or “the Patent-in-Suit…described in the ’377 patent began before 2010. The ’377 patent stems from a series of patent applications claiming… of the ’377 patent and/or the underlying patent applications that led to the ’377 patent. 38.… This is an action for patent infringement and declaratory judgment of patent infringement. Chugai brings | External link to document | |
| 2020-04-15 | 92 | Order - -Memorandum and Order | terms of U.S. Patent Nos. 9,890,377 (“the ’377 Patent”) and 10,472,623 (“the ’623 patent”) are construed… patents[, U.S. Patent Nos. 9,890,377 (“the ’377 Patent”) and 10,472,623 (“the…binds,” (’377 Patent, cl. 1, 8, & 9; ’623 Patent, cl. 1-5, 9, 10, 13, 14, &…this time, (’377 Patent, cl. 1, 8, & 9; ’623 Patent, cl. 1-5, 9, 10, 13, 14, &…region,” (’377 Patent, cl. 1, 8, & 9; ’623 Patent, cl. 1-5, 9, 10, 13, 14, & | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
